Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajkumar Ganesan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The FEBS Journal|April 21, 2010
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1)Charles Eigenbrot, Rajkumar Ganesan, Daniel Kirchhofer
The Biochemical Journal|August 14, 2010
Structural and mechanistic insight into how antibodies inhibit serine proteasesRajkumar Ganesan, Charles Eigenbrot, Daniel Kirchhofer
European Journal of Immunology|December 10, 2020
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapySundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Molecular Cancer Therapeutics|October 22, 2020
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast CancerSundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Trends in Cancer|October 12, 2020
Bispecific Antibodies for Triple Negative Breast CancerSundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Journal of Molecular Biology|June 22, 2006
Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysisRajkumar Ganesan, Peer R E Mittl, Stjepan Jelakovic, et al.
The Journal of Biological Chemistry|September 12, 2008
Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progressionManisha Tripathi, Srinivas Nandana, Hironobu Yamashita, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|August 9, 2011
In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moietyRajkumar Ganesan, Stjepan Jelakovic, Peer R E Mittl, et al.
Leukemia|February 2, 2021
Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemiaRajkumar Ganesan, Vijaykumar Chennupati, Balaji Ramachandran, et al.
Protein Engineering, Design & Selection : PEDS|January 20, 2012
An allosteric anti-hepsin antibody derived from a constrained phage display libraryRajkumar Ganesan, Yingnan Zhang, Kyle E Landgraf, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The FEBS Journal|April 21, 2010
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1)Charles Eigenbrot, Rajkumar Ganesan, Daniel Kirchhofer
The Biochemical Journal|August 14, 2010
Structural and mechanistic insight into how antibodies inhibit serine proteasesRajkumar Ganesan, Charles Eigenbrot, Daniel Kirchhofer
European Journal of Immunology|December 10, 2020
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapySundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Molecular Cancer Therapeutics|October 22, 2020
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast CancerSundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Trends in Cancer|October 12, 2020
Bispecific Antibodies for Triple Negative Breast CancerSundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Journal of Molecular Biology|June 22, 2006
Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysisRajkumar Ganesan, Peer R E Mittl, Stjepan Jelakovic, et al.
The Journal of Biological Chemistry|September 12, 2008
Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progressionManisha Tripathi, Srinivas Nandana, Hironobu Yamashita, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|August 9, 2011
In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moietyRajkumar Ganesan, Stjepan Jelakovic, Peer R E Mittl, et al.
Leukemia|February 2, 2021
Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemiaRajkumar Ganesan, Vijaykumar Chennupati, Balaji Ramachandran, et al.
Protein Engineering, Design & Selection : PEDS|January 20, 2012
An allosteric anti-hepsin antibody derived from a constrained phage display libraryRajkumar Ganesan, Yingnan Zhang, Kyle E Landgraf, et al.
Pageof 4